UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Adjuvant therapy in primary GIST: state-of-the-art

Annals of oncology, 2012-11, Vol.23 (11), p.2776-2781

2012

Volltextzugriff (PDF)

Platinum-based chemotherapy in metastatic breast cancer: current status

Cancer treatment reviews, 2004-02, Vol.30 (1), p.53-81

2004

Volltextzugriff (PDF)

7121 POSTER Bladder Preservation a Valid Option for Patients With Muscle Invasive Bladder Cancer – Single Centre Experience

European journal of cancer (1990), 2011, Vol.47, p.S510-S511

2011

Volltextzugriff (PDF)

High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: An effective first-line therapy with minimal toxicity

Annals of oncology, 2000-04, Vol.11 (4), p.427-434

2000

Volltextzugriff (PDF)

Potential of interferon-alpha in solid tumours: part 1

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2002, Vol.16 (4), p.261-281

2002

Volltextzugriff (PDF)

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy

Gynecologic oncology, 2004-08, Vol.94 (2), p.502-508

2004

Volltextzugriff (PDF)

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

British journal of cancer, 2002-07, Vol.87 (1), p.15-20

2002

Volltextzugriff (PDF)

P2.17-07 Concurrent Chemoradiotherapy (ConCRT) using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S854-S854

2018

Volltextzugriff (PDF)

Dermatomyositis as a Paraneoplastic Syndrome in Carcinosarcoma of Uterine Origin

Clinical oncology (Royal College of Radiologists (Great Britain)), 2006-11, Vol.18 (9), p.641-648

2006

Volltextzugriff (PDF)

P3.01-22 An Exploratory Analysis of PD-L1 Expression and Smoking History in a Cohort of Advanced Non-Small Cell Lung Cancer Patients

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S875-S876

2018

Volltextzugriff (PDF)

Programmed death-ligand 1 (PD-L1) expression and testing experience in a cohort of advanced non-small cell lung cancer (NSCLC) patients

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S42

2018

Volltextzugriff (PDF)

100 - Programmed death-ligand 1 (PD-L1) expression and testing experience in a cohort of advanced non-small cell lung cancer (NSCLC) patients

Lung cancer (Amsterdam, Netherlands), 2018-01, Vol.115, p.S42-S42

2018

Volltextzugriff (PDF)

Platinum-based Chemotherapy in Metastatic Breast Cancer: The Leicester (UK) Experience

Clinical oncology (Royal College of Radiologists (Great Britain)), 2005-06, Vol.17 (4), p.249-257

2005

Volltextzugriff (PDF)

Cure without complications: a population-based analysis of treatment intensity and survival in testicular germ cell tumours

Clinical oncology (Royal College of Radiologists (Great Britain)), 2003-04, Vol.15 (2), p.84

2003

Volltextzugriff (PDF)

Potential of interferon-alpha in solid tumours: part 2

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2002, Vol.16 (5), p.349-372

2002

Volltextzugriff (PDF)

Adjuvant therapy in primary GIST: state-of-the-art

Annals of oncology, 2012-11, Vol.23 (11), p.2776

2012

Volltextzugriff (PDF)

Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results of a single-agent phase 2 study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4030-4030

2004

Volltextzugriff (PDF)

Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results of a single-agent phase 2 study

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4030-4030

2004

Volltextzugriff (PDF)

Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy

Cancer chemotherapy and pharmacology, 2003-11, Vol.52 (5), p.367-370

2003

Volltextzugriff (PDF)

85: Single MDT 30-day mortality after systemic anticancer therapy (SACT) for lung cancer in an NHS trust serving an English and Welsh population

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S40-S40

2017

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Adjuvant therapy in primary GIST: state-of-the-art

Platinum-based chemotherapy in metastatic breast cancer: current status

7121 POSTER Bladder Preservation a Valid Option for Patients With Muscle Invasive Bladder Cancer – Single Centre Experience

High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: An effective first-line therapy with minimal toxicity

Potential of interferon-alpha in solid tumours: part 1

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

P2.17-07 Concurrent Chemoradiotherapy (ConCRT) using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)

Dermatomyositis as a Paraneoplastic Syndrome in Carcinosarcoma of Uterine Origin

P3.01-22 An Exploratory Analysis of PD-L1 Expression and Smoking History in a Cohort of Advanced Non-Small Cell Lung Cancer Patients

Programmed death-ligand 1 (PD-L1) expression and testing experience in a cohort of advanced non-small cell lung cancer (NSCLC) patients

100 - Programmed death-ligand 1 (PD-L1) expression and testing experience in a cohort of advanced non-small cell lung cancer (NSCLC) patients

Platinum-based Chemotherapy in Metastatic Breast Cancer: The Leicester (UK) Experience

Cure without complications: a population-based analysis of treatment intensity and survival in testicular germ cell tumours

Potential of interferon-alpha in solid tumours: part 2

Adjuvant therapy in primary GIST: state-of-the-art

Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results of a single-agent phase 2 study

Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results of a single-agent phase 2 study

Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy

85: Single MDT 30-day mortality after systemic anticancer therapy (SACT) for lung cancer in an NHS trust serving an English and Welsh population

Suchergebnisse filtern